MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 12.05.2026
Waters Corporation Anteile 2011-2026 | WAT
Anteile Jährlich Waters Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.5 M | 59.4 M | 59.1 M | 60 M | 61.6 M | 62.1 M | 67.6 M | 77 M | 79.8 M | 80.8 M | 82.3 M | 84.4 M | 85.4 M | 87.8 M | 90.8 M | 92.4 M | 95.8 M | 99.2 M | 100 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 100 M | 59.1 M | 78.2 M |
Anteile Vierteljährlich Waters Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.1 B | 59.5 M | 59.5 M | 59.4 M | 59.4 M | 59.4 M | 59.3 M | 59.2 M | 59.2 M | 59.1 M | 58.9 M | 59 M | 59.1 M | 59.8 M | - | 60.6 M | 60.7 M | 61.4 M | 61.7 M | 62.3 M | 62.2 M | 62 M | 61.9 M | 62.2 M | 63.8 M | 66.2 M | 69 M | 71.7 M | 74.8 M | 76.6 M | 77.8 M | 78.9 M | 79.5 M | 79.7 M | 80 M | 80.1 M | 80.4 M | 80.7 M | 80.8 M | 81.3 M | 81.6 M | 82 M | 82.6 M | 83 M | 83.2 M | 83.7 M | 84.5 M | 85 M | 85 M | 85.2 M | 85.5 M | 86 M | 86.7 M | 87.4 M | 88.3 M | 89 M | 89.3 M | 90.7 M | 91.7 M | 91.6 M | 91.7 M | 92.6 M | 93.6 M | 95.2 M | 96.1 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 82.1 B | 58.9 M | 1.36 B |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
46.8 M | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
125 M | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
78.4 M | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
155 M | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
20.6 M | - | - | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | - | - | $ 6.94 B | USA |
 |
NeoGenomics
NEO
|
128 M | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
Natera
NTRA
|
137 M | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
89.2 M | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 25.99 | 2.52 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.3 M | - | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | - | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
359 M | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |